AxoGen Q3 Revenue USD 75.8 Million Vs. IBES Estimate USD 73.2 Million

By Reuters News

Oct 28 (Reuters) - AxoGen Q3 adjusted net income USD 13.1 million.

  • Q3 adjusted EBITDA USD 13.4 million
  • Q3 gross margin 74.8%
  • Q3 net income USD 2.3 million
  • outlook FY revenue USD 290 million vs. IBES estimate USD 283.2 million

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk